La Via L et al., 2025-06-24: Narrative review of hepatopulmonary syndrome concluding that liver transplantation remains the only curative therapy.
Transplantation demonstrates excellent outcomes independent of disease severity, while optimal timing requires an individualized approach.
La Via L et al., 2025-06-24: Narrative review of hepatopulmonary syndrome concluding that liver transplantation remains the only curative therapy. C10. Study type: narrative review (Curr Opin Anaesthesiol 2025;38:485-491); A.O.U. (Italy). No patients; states HPS affects up to 30% of cirrhotic patients and more than doubles mortality. Bearing PARTLY because the review's therapeutic conclusion is transplantation, not methylene blue; methylene blue is not named as an established therapy in the abstract captured. Funder/conflicts not stated. Study type: review.
